Abiopharma

🔍 Lilly Elizabeth Murphy (Director)

Company: APOGEE ENTERPRISES, INC. (APOG)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 55 shares of Deferred Restricted Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 6,900.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3, F3

Footnotes:

• F1: Settled 1-for-1.
• F2: Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.
• F3: The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.